Home LiteratureArticle Details
PMID: 9416506 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.

Immunological reviews ·Vol. 159 ·1997-10-00 ·Pages 105-17

Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, Stevenson PG

Abstract

The rules for T-cell-mediated control of viruses that infect via the respiratory mucosae show both common themes and differences, depending on the nature of the pathogen. Virus-specific CD8+ cytotoxic T lymphocytes (CTLs) are the key effectors of virus clearance in mice infected with both negative strand RNA viruses (influenza and Sendai) and a DNA virus, the murine gamma-herpesvirus-68 (MHV-68). Recently completed experiments establish that these activated CD8+ T cells indeed operate primarily via contact-dependent lysis. Perforin-mediated cytotoxicity seems to be the preferred mode, though a Fas-based mechanism can apparently serve as an alternative mechanism. Immune CD4+ T cells functioning in the absence of the CD8+ subset cannot eliminate MHV-68 from lung epithelial cells, are somewhat less efficient than the CD8+ CTLs at clearing the RNA viruses, and are generally ineffectual in mice that lack B lymphocytes. Though cytokine secretion by CD4+ and CD8+ T cells in the virus-infected lung may promote both T-cell extravasation and macrophage activation, such processes are not alone sufficient to deal consistently with any of these infections. However, CD4+ T help is mandatory for an effective B-cell response, and can operate to promote the clonal expansion of virus-specific CD8+ T cells in the lymph nodes and spleen. Furthermore, a concurrent CD4+ T-cell response seems to be essential for maintaining continued CD8+ T-cell surveillance and effector capacity through the persistent, latent phase of MHV-68 infection in B cells. Thus, the evidence to date supports a very traditional view; CD8+ T cells function mainly as killers and the CD4+ T cells as helpers in these respiratory virus infections.

MeSH Terms
Animals B-Lymphocytes/immunology CD4-Positive T-Lymphocytes/immunology CD8-Positive T-Lymphocytes/immunology Cytotoxicity, Immunologic Mice Pneumonia, Viral/immunology Respiratory Tract Diseases/immunology,virology
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Doherty P C
St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. peter.doherty@stjude.org
Topham D J
Tripp R A
Cardin R D
Brooks J W
Stevenson P G
Article Info
Journal
Immunological reviews
Abbr.
Immunol Rev
ISSN
0105-2896
Published
1997-10-00
Pages
105-17
Language
English
Region
England
NLM ID
7702118
Subset
IM
Grants
NIAID NIH HHS · AI28359 · United States
NIAID NIH HHS · AI29579 · United States
NCI NIH HHS · CA09346 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com